Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Cervical cancer is a type of cancer that occurs in the cells of the cervix — the lower part of the uterus that connects to the vagina. Pap smear, colposcopy, and ECC procedure are some of the tests used in diagnosis of cervical cancer.

Statistics:

The global cervical cancer diagnostic tests market is estimated to account for US$ 93.6 Mn in terms of value by the end of 2027.

Global Cervical Cancer Diagnostic Tests Market: Drivers

Increasing prevalence of cervical cancer is expected to propel growth of the global cervical cancer diagnostic tests market over the forecast period. For instance, according to the American Cancer Society, about 13,800 new cases of invasive cervical cancer are expected to be diagnosed in the U.S. in 2020 and the disease is expected to lead to death of 4,290 women in the same year.

Moreover, high number of smoking women is also expected to aid in growth of the market.  Tobacco by-products have been found in the cervical mucus of women who smoke. According to Truth Initiative, the U.S.-based nonprofit public health organization, (March 2019), among high school students in the U.S., 7.3 percent of females and 8.8 percent of males currently smoke cigarettes.

Statistics:

North America held dominant position in the global cervical cancer diagnostic tests market in 2019, accounting for 37.0% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1: Global Cervical Cancer Diagnostic Tests Market Share (%) Value, By Region, 2019

Cervical Cancer Diagnostic Tests  | Coherent Market Insights

Global Cervical Cancer Diagnostic Tests Market: Restraints

Stringent regulations and guidelines are expected to hinder growth of the market. Government recommendations and regulations suggest the initial age limit to be 21 for a pap test. American College of Obstetricians and Gynecologists suggests that the initial age limit for a pap smear test should be 21 or within the first three years of the first sexual intercourse, to avoid unnecessary treatment expenses.

Moreover, lack of appropriate healthcare infrastructure in underdeveloped and developing countries is also expected to limit the market growth.

request-sample

Cervical Cancer Diagnostic Tests Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 77.1 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 2.4% 2027 Value Projection: US$ 93.6 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Test Type: Pap Smear Test Procedure, Colposcopy Procedure, ECC Procedures.
  • By Age Group: Age 20 - 40, Age above 40.
Companies covered:

Guided Therapeutics, Abbott Laboratories, Beckman Coulter Inc., and Becton, Dickinson and Company.

Growth Drivers:
  • Increasing prevalence of cervical cancer
  • Approval and launch of new products
Restraints & Challenges:
  • Stringent regulatory guidelines

Global Cervical Cancer Diagnostic Tests Market: Opportunities

Increasing female geriatric population is expected to offer lucrative growth opportunities for players in the global cervical cancer diagnostic tests market. For instance, according to the U.S. Census Bureau, women aged 85 and older are projected to make up 2.9 percent of the total U.S. population in 2060.

Moreover, increasing prevalence of obesity is also expected to aid in growth of the market. For instance, according to the Centers of Disease Control and Prevention, Behavioral Risk Factor Surveillance System, 2018, 71424.3 thousand people in the U.S. suffer from obesity. 

Statistics:

The global cervical cancer diagnostic tests market was valued at US$ 77.1 Mn in 2019 and is forecast to reach a value of US$ 93.6 Mn by 2027 at a CAGR of 2.4% between 2020 and 2027.

Figure 2: Global Cervical Cancer Diagnostic Tests Market Value (US$ Mn), 2016 – 2027

Cervical Cancer Diagnostic Tests  | Coherent Market Insights

Market Trends/Key Takeaways

Major healthcare bodies are focused on promoting at-home screening for HPV and cervical cancer. For instance, in the U.S., The National Cancer Institute plans to launch a multisite study in 2021 involving roughly 5,000 women to assess whether self-sampling at home is comparable to screening in the office by a clinician.

Use of artificial intelligence (AI) is expected to enhance the efficacy of cervical cancer diagnostics. For instance, according to a study published in June 2020, in the Journal of the National Cancer Institute, a computer algorithm improved the accuracy and efficiency of cervical cancer screening compared with cytology (Pap test), the current standard for follow-up of women who test positive with primary human papillomavirus (HPV) screening.

Global Cervical Cancer Diagnostic Tests Market: Competitive Landscape

Major players operating in the global cervical cancer diagnostic tests market include, Guided Therapeutics, Abbott Laboratories, Beckman Coulter Inc., and Becton, Dickinson and Company.

Global Cervical Cancer Diagnostic Tests Market: Key Developments

Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in July 2020, Guided Therapeutics, Inc. received a new CE Mark, through its European contract manufacturer, Newmars Technologies, Kft., for its LuViva Advanced Cervical Scan.

Similarly, in March 2019, Abbott Laboratories received CE Mark for its Alinity m diagnostics system and assays.

Cervical Cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedure are performed for the diagnosis of cervical cancer. Increasing product approval, along with increasing prevalence of cervical cancer in developing economies is expected to assist the growth of the market during the forecast period. Furthermore, increasing awareness regarding cervical cancer in developing economies and increasing funding for R&D in diagnosis of cervical cancer is also anticipated to drive the growth of the market during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Cervical Cancer Diagnostic Tests market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Cervical Cancer Diagnostic Tests market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Guided Therapeutics, Abbott Laboratories, Beckman Coulter Inc., and Becton, Dickinson and Company.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Cervical Cancer Diagnostic Tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cervical Cancer Diagnostic Tests market

Detailed Segmentation:

  • Global Cervical Cancer Diagnostic Tests Market, By Test Type:
    • Pap Smear Test Procedure
    • Colposcopy Procedure
    • ECC Procedures
  • Global Cervical Cancer Diagnostic Tests Market, By Age Group:
    • Age 20 - 40
    • Age above 40
  • Global Cervical Cancer Diagnostic Tests Market, By Region:
    • North America
      • By Test Type:
        • Pap Smear Test Procedure
        • Colposcopy Procedure
        • ECC Procedures
      • By Age Group
        • Age 20 - 40
        • Age above 40
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Test Type:
        • Pap Smear Test Procedure
        • Colposcopy Procedure
        • ECC Procedures
      • By Age Group
        • Age 20 - 40
        • Age above 40
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Test Type:
        • Pap Smear Test Procedure
        • Colposcopy Procedure
        • ECC Procedures
      • By Age Group
        • Age 20 - 40
        • Age above 40
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Test Type:
        • Pap Smear Test Procedure
        • Colposcopy Procedure
        • ECC Procedures
      • By Age Group
        • Age 20 - 40
        • Age above 40
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Test Type:
        • Pap Smear Test Procedure
        • Colposcopy Procedure
        • ECC Procedures
      • By Age Group
        • Age 20 - 40
        • Age above 40
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Test Type:
        • Pap Smear Test Procedure
        • Colposcopy Procedure
        • ECC Procedures
      • By Age Group
        • Age 20 - 40
        • Age above 40
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Guided Therapeutics *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test Type
      • Market Snippet, By Age Group
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
    • COVID19 Impact on Market
  4. Global Cervical Cancer Diagnostic Tests Market, By Test Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Pap Smear Test Procedure
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Colposcopy Procedure
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • ECC Procedures
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Cervical Cancer Diagnostic Tests Market, By Age Group, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Age 20 - 40
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Age above 40
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Cervical Cancer Diagnostic Tests Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Test Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Guided Therapeutics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Beckman Coulter Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 18 market data tables and 12 figures on “Cervical Cancer Diagnostic Tests Market - Global forecast to 2027”.

Frequently Asked Questions

The Global Cervical Cancer Diagnostic Tests market size was valued at US$ 77.1 million in 2019 and is estimated to exhibit a CAGR of 2.4% between 2020 and 2027.
Colposcopy Procedure segment held the major market share in 2019 owing to an increasing prevalence of cervical cancer over the forecast period.
Major factor driving the growth of Global Cervical Cancer Diagnostic Tests market during the forecast period increasing prevalence of cervical cancer, and increasing adoption of at-home screening services.
Major factors hampering the growth of the Global Cervical Cancer Diagnostic Tests market during the forecast period constitutes of stringent regulations and guidelines.
North America market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Guided Therapeutics, Abbott Laboratories, Beckman Coulter Inc., and Becton, Dickinson and Company.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner